Now Playing
Opinion|Videos|August 21, 2024
Overview Of Central Precocious Puberty
Key opinion leaders offer insights into the pathogenesis and essential features of CPP, along with additional symptoms that clinicians should monitor.
Advertisement
Episodes in this series
Video content above is prompted by the following:
- Can you provide an overview of CPP pathogenesis and key characteristics?
- What signs and symptoms should a clinician be aware of?
Advertisement
Related to this article
Glucommander Pediatrics received FDA Breakthrough Device Designation for IV insulin dosing in hospitalized children younger than 2 years, but remains uncleared.
ISPAD, EASD, and ADA urge pediatric diabetes teams to build center-specific transition policies, use readiness checklists, and ensure timely handoffs to adult clinicians.
Advertisement
Advertisement
Trending on Contemporary Pediatrics
1
BLA submitted to FDA for Viaskin peanut patch in children aged 4 to 7 years with peanut allergy
2
Ecopipam data at MDS 2026 show early and sustained tic reduction in pediatric Tourette syndrome
3
Osteopathic treatment shows safety in infants with plagiocephaly
4
FDA approves expandable Autus valve for congenital pulmonary valve disease
5